Atlas Trials

A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Clinical trial NCT05022004 · COMPLETED

Trial details

NCT number
NCT05022004
Sponsor
Sun Pharmaceutical Industries Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Open Angle GlaucomaOcular Hypertension
Start date
2021-12-20
Primary completion
2022-12-29
Enrollment
599

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.